Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?

Literature DB >> 19349474

Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?

Christos S Mantzoros.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2009 PMID： 19349474 PMCID： PMC2730231 DOI： 10.1210/jc.2009-0340

Source DB: PubMed Journal: J Clin Endocrinol Metab ISSN： 0021-972X Impact factor: 5.958

× No keyword cloud information.

20 in total

1. Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy.

Authors: M Depairon; S Chessex; P Sudre; N Rodondi; N Doser; J P Chave; W Riesen; P Nicod; R Darioli; A Telenti; V Mooser
Journal: AIDS Date: 2001-02-16 Impact factor: 4.177

Review 2. Clinical review 159: Human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies.

Authors: M K S Leow; C L Addy; C S Mantzoros
Journal: J Clin Endocrinol Metab Date: 2003-05 Impact factor: 5.958

Review 3. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

Authors: Steven Grinspoon; Andrew Carr
Journal: N Engl J Med Date: 2005-01-06 Impact factor: 91.245

4. Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin.

Authors: G Sonia Nagy; Sotirios Tsiodras; Lizabeth D Martin; Anchalee Avihingsanon; Alina Gavrila; William C Hsu; Adolf W Karchmer; Christos S Mantzoros
Journal: Clin Infect Dis Date: 2003-03-05 Impact factor: 9.079

5. Leptin-replacement therapy for lipodystrophy.

Authors: Elif Arioglu Oral; Vinaya Simha; Elaine Ruiz; Alexa Andewelt; Ahalya Premkumar; Peter Snell; Anthony J Wagner; Alex M DePaoli; Marc L Reitman; Simeon I Taylor; Phillip Gorden; Abhimanyu Garg
Journal: N Engl J Med Date: 2002-02-21 Impact factor: 91.245

6. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.

Authors: Kitt Falk Petersen; Elif Arioglu Oral; Sylvie Dufour; Douglas Befroy; Charlotte Ariyan; Chunli Yu; Gary W Cline; Alex M DePaoli; Simeon I Taylor; Phillip Gorden; Gerald I Shulman
Journal: J Clin Invest Date: 2002-05 Impact factor: 14.808

7. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.

Authors: Kathleen Mulligan; Hootan Khatami; Jean-Marc Schwarz; Giorgos K Sakkas; Alex M DePaoli; Viva W Tai; Michael J Wen; Grace A Lee; Carl Grunfeld; Morris Schambelan
Journal: J Clin Endocrinol Metab Date: 2009-01-27 Impact factor: 5.958

8. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.

Authors: Carol L Addy; Alina Gavrila; Sotirios Tsiodras; Kimberly Brodovicz; Adolf W Karchmer; Christos S Mantzoros
Journal: J Clin Endocrinol Metab Date: 2003-02 Impact factor: 5.958

9. Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients.

Authors: Donald P Kotler; Norma Muurahainen; Carl Grunfeld; Christine Wanke; Melanie Thompson; Michael Saag; Daena Bock; Gregg Simons; Joseph M Gertner
Journal: J Acquir Immune Defic Syndr Date: 2004-03-01 Impact factor: 3.731

10. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.

Authors: T Yamauchi; J Kamon; H Waki; Y Terauchi; N Kubota; K Hara; Y Mori; T Ide; K Murakami; N Tsuboyama-Kasaoka; O Ezaki; Y Akanuma; O Gavrilova; C Vinson; M L Reitman; H Kagechika; K Shudo; M Yoda; Y Nakano; K Tobe; R Nagai; S Kimura; M Tomita; P Froguel; T Kadowaki
Journal: Nat Med Date: 2001-08 Impact factor: 53.440

10 in total

1. Repositioning leptin as a therapy for Alzheimer's disease.

Authors: Jane M Johnston; Steven J Greco; Ashkan Hamzelou; J Wesson Ashford; Nikolaos Tezapsidis
Journal: Therapy Date: 2011-09

Review 2. Lipodystrophy: pathophysiology and advances in treatment.

Authors: Christina G Fiorenza; Sharon H Chou; Christos S Mantzoros
Journal: Nat Rev Endocrinol Date: 2010-11-16 Impact factor: 43.330

Review 3. Leptin in human physiology and pathophysiology.

Authors: Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal: Am J Physiol Endocrinol Metab Date: 2011-07-26 Impact factor: 4.310

4. Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment.

Authors: Faidon Magkos; Christos S Mantzoros
Journal: Metabolism Date: 2010-10-20 Impact factor: 8.694

Review 5. Leptin in human physiology and therapeutics.

Authors: Tina A Dardeno; Sharon H Chou; Hyun-Seuk Moon; John P Chamberland; Christina G Fiorenza; Christos S Mantzoros
Journal: Front Neuroendocrinol Date: 2010-06-17 Impact factor: 8.606

6. Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood.

Authors: David Dimock; Vijaya Thomas; Anna Cushing; Julia B Purdy; Carol Worrell; Jeffrey B Kopp; Rohan Hazra; Colleen Hadigan
Journal: Metabolism Date: 2010-10-13 Impact factor: 8.694